SI-BONE Stock (NASDAQ:SIBN)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$17.25

52W Range

$11.70 - $20.05

50D Avg

$18.11

200D Avg

$15.61

Market Cap

$750.02M

Avg Vol (3M)

$480.04K

Beta

0.93

Div Yield

-

SIBN Company Profile


SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers iFuse, a minimally invasive surgical implant system to address sacroiliac joint dysfunction and degeneration, adult deformity, and pelvic ring traumatic fractures. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; and iFuse-TORQ, a set of 3D-printed threaded implants designed to treat fractures of the pelvis and for minimally invasive sacroiliac joint fusion. It markets its products primarily with a direct sales force, as well as through distributors. The company was incorporated in 2008 and is headquartered in Santa Clara, California.

Show More

Industry

Medical - Devices

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

349

IPO Date

Oct 17, 2018

Website

SIBN Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceJun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20
UNITED STATES$31.21M$30.45M$29.99M$24.63M$23.77M$20.37M$23.35M$20.39M$20.23M$18.77M$20.68M$18.92M
Non-US$2.09M$2.26M$1.97M$1.80M$1.81M$2.07M$1.88M$1.89M$1.96M$1.67M$1.47M$1.45M

Fiscal year ends in Dec 24 | Currency in USD

SIBN Financial Summary


Dec 24Dec 23Dec 22
Revenue$167.18M$138.89M$106.41M
Operating Income$-35.25M$-46.93M$-59.61M
Net Income$-30.91M$-43.34M$-62.90M
EBITDA$-35.25M$-34.45M$-54.98M
Basic EPS$-0.75$-1.13$-1.84
Diluted EPS$-0.75$-1.13$-1.84

Fiscal year ends in Dec 24 | Currency in USD

Latest Earnings Call Transcripts


Q1 25May 05, 25 | 4:30 PM
Q4 24Feb 24, 25 | 4:30 PM
Q3 24Nov 12, 24 | 4:30 PM

Peer Comparison


TickerCompany
KIDSOrthoPediatrics Corp.
CRNXCrinetics Pharmaceuticals, Inc.
SGHTSight Sciences, Inc.
TCMDTactile Systems Technology, Inc.
RXSTRxSight, Inc.
STROSutro Biopharma, Inc.
OFIXOrthofix Medical Inc.